Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Journal of Personalized Medicine
|
September 28, 2023
ReLiFiRa (Real Life Filgotinib in Rheumatoid Arthritis): Retrospective Study of Efficacy and Safety in Common Clinical Practice
Maurizio Benucci, Marco Bardelli, Massimiliano Cazzato, et al.
Autoimmunity Reviews
|
October 31, 2021
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience
Elana Agostini, Giacomo De Luca, Cosimo Bruni, et al.
Journal of Personalized Medicine
|
July 27, 2024
Efficacy and Safety of Filgotinib in Rheumatoid Arthritis Patients Aged over and under 65 Years (ENANTIA-65)
Maurizio Benucci, Marco Bardelli, Massimiliano Cazzato, et al.
Clinical and Experimental Rheumatology
|
October 3, 2018
The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interaction
Ginevra Fiori, Tessa Marzi, Francesca Bartoli, et al.
Therapeutic Advances in Musculoskeletal Disease
|
November 2, 2020
The switch from etanercept originator to SB4: data from a real-life experience on tolerability and persistence on treatment in joint inflammatory diseases
Cosimo Bruni, Stefano Gentileschi, Giovanni Pacini, et al.
Frontiers in Pediatrics
|
April 4, 2025
Urinary biomarkers improve prediction of AKI in pediatric cardiac surgery
Oscar T Deal, Thomas Mitchell, Amy G Harris, et al.
Annals of the Rheumatic Diseases
|
March 16, 2007
Reduced circulating levels of angiotensin-(1--7) in systemic sclerosis: a new pathway in the dysregulation of endothelial-dependent vascular tone control
Alberto Pignone, Angela Del Rosso, K Bridget Brosnihan, et al.
Rheumatology (Oxford, England)
|
May 23, 2020
EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies
Francesca Pregnolato, Maria Gerosa, Maria Gabriella Raimondo, et al.
Annals of the New York Academy of Sciences
|
September 26, 2007
Flow-mediated vasodilation and carotid intima-media thickness in systemic sclerosis
Francesca Bartoli, Jelena Blagojevic, Marzia Bacci, et al.
Therapeutic Advances in Musculoskeletal Disease
|
February 4, 2022
Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis
Cosimo Bruni, Stefano Gentileschi, Giovanni Pacini, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Journal of Personalized Medicine
|
September 28, 2023
ReLiFiRa (Real Life Filgotinib in Rheumatoid Arthritis): Retrospective Study of Efficacy and Safety in Common Clinical Practice
Maurizio Benucci, Marco Bardelli, Massimiliano Cazzato, et al.
Autoimmunity Reviews
|
October 31, 2021
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience
Elana Agostini, Giacomo De Luca, Cosimo Bruni, et al.
Journal of Personalized Medicine
|
July 27, 2024
Efficacy and Safety of Filgotinib in Rheumatoid Arthritis Patients Aged over and under 65 Years (ENANTIA-65)
Maurizio Benucci, Marco Bardelli, Massimiliano Cazzato, et al.
Clinical and Experimental Rheumatology
|
October 3, 2018
The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interaction
Ginevra Fiori, Tessa Marzi, Francesca Bartoli, et al.
Therapeutic Advances in Musculoskeletal Disease
|
November 2, 2020
The switch from etanercept originator to SB4: data from a real-life experience on tolerability and persistence on treatment in joint inflammatory diseases
Cosimo Bruni, Stefano Gentileschi, Giovanni Pacini, et al.
Frontiers in Pediatrics
|
April 4, 2025
Urinary biomarkers improve prediction of AKI in pediatric cardiac surgery
Oscar T Deal, Thomas Mitchell, Amy G Harris, et al.
Annals of the Rheumatic Diseases
|
March 16, 2007
Reduced circulating levels of angiotensin-(1--7) in systemic sclerosis: a new pathway in the dysregulation of endothelial-dependent vascular tone control
Alberto Pignone, Angela Del Rosso, K Bridget Brosnihan, et al.
Rheumatology (Oxford, England)
|
May 23, 2020
EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies
Francesca Pregnolato, Maria Gerosa, Maria Gabriella Raimondo, et al.
Annals of the New York Academy of Sciences
|
September 26, 2007
Flow-mediated vasodilation and carotid intima-media thickness in systemic sclerosis
Francesca Bartoli, Jelena Blagojevic, Marzia Bacci, et al.
Therapeutic Advances in Musculoskeletal Disease
|
February 4, 2022
Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis
Cosimo Bruni, Stefano Gentileschi, Giovanni Pacini, et al.
Page
of 5